Ellevest, Inc. Catalent, Inc. Transaction History

Ellevest, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$45.44 - $74.26 $45 - $74	1 Added 1.33%	76 $4,000
Q4 2022 Feb 03, 2023	SELL	$41.39 - $81.0 $2,897 - $5,670	-70 Reduced 48.28%	75 $3,000
Q3 2022 Nov 02, 2022	SELL	$72.36 - $113.1 $10,130 - $15,834	-140 Reduced 49.12%	145 $10,000
Q2 2022 Jul 18, 2022	SELL	$87.2 - $114.05 $10,551 - $13,800	-121 Reduced 29.8%	285 $31,000
Q1 2022 Apr 19, 2022	BUY	$94.19 - $124.49 $10,831 - $14,316	115 Added 39.52%	406 $45,000
Q4 2021 Jan 24, 2022	BUY	$119.57 - $139.07 $478 - $556	4 Added 1.39%	291 $37,000
Q3 2021 Oct 19, 2021	SELL	$109.17 - $142.35 $139,082 - $181,353	-1,274 Reduced 81.61%	287 $38,000
Q2 2021 Jul 13, 2021	BUY	$100.34 - $115.69 $301 - $347	3 Added 0.19%	1,561 $169,000
Q1 2021 May 03, 2021	BUY	$101.51 - $125.27 $41,923 - $51,736	413 Added 36.07%	1,558 $164,000
Q4 2020 Feb 04, 2021	BUY	$85.88 - $105.36 $53,589 - $65,744	624 Added 119.77%	1,145 $119,000
Q3 2020 Oct 26, 2020	BUY	$72.74 - $92.5 $37,897 - $48,192	521 New	521 $45,000

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.